HLA-G and triple-negative breast carcinoma: Interestingly in triple negative breast cancer the HLA-G 3 ́UTR haplotypes was not associated with disease outcome, however, high levels of sHLA-G combined with the LILRB1-PROMO rs10416697C allele being part of the here defined LILRB1-PROMO CG haplotype, were associated in adverse disease outcome in uni- and multivariate analysis (47).